_id

690db013ccc777a4e85d0b51

Ticker

APVO

Name

Aptevo Therapeutics Inc

Exchange

NASDAQ

Address

2401 4th Avenue, Seattle, WA, United States, 98121

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://aptevotherapeutics.com

Description

Aptevo Therapeutics Inc., a clinical-stage research and development biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. The company develops its products using ADAPTIR and ADAPTIR-FLEX platforms to generate monospecific, bispecific, and multi-specific antibody candidates capable of enhancing the human immune system against cancer cells. Its lead clinical blood cancer candidate is mipletamig that is in Phase 1b/2 clinical trial for the treatment of acute myelogenous leukemia. The company also develops ALG.APV-527, a novel investigational bispecific ADAPTIR candidate that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer, head and neck, colorectal, pancreatic, breast, and other solid tumors; APVO603, a preclinical dual agonist bispecific ADAPTIR candidate to treat multiple solid tumors; APVO442, a preclinical bispecific candidate based on the ADAPTIR-FLEX platform technology for the treatment of multiple solid tumors; and APVO711, a preclinical dual mechanism bispecific ADAPTIR candidate to treat prostate cancer. It has a collaboration and option agreement with Alligator Bioscience AB to develop ALG.APV-527. Aptevo Therapeutics Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Last Close

1.16

Volume

468879

Current Price

1.13

Change

-2.5862068965517264

Last Updated

2025-11-28T12:19:34.589Z

Image

data:image/webp;base64,UklGRjIGAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSHUDAAABoERteyFR+v4kVde2bdtc3bFt27Zt27Zt27ZtT6eS/1u0qruGu4iYAPy/aIy1zrmksnPOWpFmMc6lBrmKS6xplLjUAhC07jdm1pIV19hg00033XSTddZYYfG0EV0tANjESn6SAECn6Stvc/jF9zz/0W+sMXz7zpM3nLrnOvN7C4DU5gW0Xrz18Te/+QeV5TEr/VnuM2XF8PE9p2w10wGJzSfd9NaPqKRmJZ+FGFVZWTXGzPs/I6l8+5qdx0ISqU/Qhxm1lMXI3DVkpUjy5ZOnw0hdQMsz+EdgwzVkSr67t5gc0OJwZqFhJDUE6glwOcCu/RF9E5DM+HYfmPoEmHAXveaiWkfk6+1E6gMMOhzLEGtSjTEEZYy1keciQa4CrPEpQwUtZ7l+/8Gv1FqUH/eHyQcQDLmRWlaub918zKZzenfs0Pkyhhr4+2awyF9k7hnPf/je4xfvs+qYti2cAECK3Ri1mp4EiwaLMYKqxrUZs84VP1FZ/QYYNKWkrTuMWW3/K179k8qa73RStTEyYscrXvKsqKq13JWgRpHcRLp/RWUM5ZG1/H6Za9WpZ/8BgwcP6N05BUTyMi2epUbWrbxn9rZn3/vO7yTjFw+dsHQfB5MPBDPeIOl/+OytFx+6/LzXqWXkV5EkY8h8UEa+tW03mHxgMO6oC07aa90FA1Kk2JxRK7DksxBVSdWYlTzvmwTJBxZVbWu0ObOass74J9+aiLxt2iJNnLUJ+lzKqKxdY/Del0o++5WPdoHkU1msLH6ambLW6D1rzbidoIEiySYf0yurR+9JZu89cuMFp59w7MnnXnXns490aoBIutuvwbN6LJF898p915wzuIOgvGWPsUu1zE9gd85CxqpaUv50+WbT26NcrHPOoNFrlUJkVR/5yVELOwBwibNGRCBijHWNmPqDBlZWH389ZrIBnDVo2nYvMrBy8Lx5rgWsoInlaAZW9vrddm0BI2jqyYFVPR+fCRhBk9/OqoGXdYcRlKdNNFUrqfK4BAYVRZpGcAErKuMBMIKml9Y/VlDG/WHR/ILlfJmSh8OhgAYnkKSSZ8KhiBYPl5G3WCMF+YSk8oXuEBTSuO9J5beLYFFIkfY/UOn3QIKidPiB5G1IUVSLb8kvB4sU6D3G7WFQoNv5jLEorsGhXIgiC+bfYAsFpANMwYovpmj/sQMAVlA4IJYCAABwDQCdASpAAEAAPrVSoUsnJSMhrBVbMOAWiWwAwYf6/TIuvAHoA2wHPXeij/L74fvFq/BWtoAPZlRAeub9gPYA/Ss9WWPsNlClhWPMced6MLraLI+/z+WZVFqoRA5wsKsFgkOU/Qg6P1Gyn9UiTR13KKAUwAD+/VPvqeFdj2VsibpUa+xQXOkY8hxV0biAk1UnQU8TwBoqiKZgjskotcwadkSNe/+JUO8RKDpiWB8v+lOwT0+LtCmiB3KNOIsxX5eFZm8eox20ztg2dGHqM+cIG+LcX/fighBc/TCTk7XUo3Y0VWvTQMw4KN6x3ZqzFEZxs3K1iWdRX+DX6ogFGH4gxesvMaHIS2ylbvt0tqVT00UfIykQirVRI2nNFNUDb/t14m6nNNJdPOin0Ekus6EddC9kGMLbh63UEb3OYm5xxMmVXYvjMEr9MkDUV2swhwJa61iI1ZKVDTYf8WiTOVYiBeTScm7gj3yEPRu5B8vfchQwZDOL0MIFYxViEN0vl1m7lHF1339Wp2F27hISvSG98wLGaZXpZaCWel2eCyfkahZP3PL+//Mo6QnuWrDnoqY1gxK/y0s4vjzW8Vgb+I+sFPD80NZPPOMx4B0Dnq/L33gilSdWHIXVxsnApIeDRlHvtu63CQa7L+XseVJGQDU+kK0wpX+yXpBadIBVbdYbldG8EPK0aI7CNLAaYoy73pH8nyYKrp8AODZAo8dFjzHPacxR195zS84EwC7be6qfwWC7c+ARaEYM/+kegdXxD40Jz3jCMJeYsNflAqvJxPih9P5NHZwHI4guNXWb7bLZO6JtRzzKG+ygK1D3h2I7NdYU8a6zTeP9fVjO9X7hUZ7+AHVHpcrRAwkNPcORj9SqXzWxEaAAAA==

Ipo Date

2016-07-20T00:00:00.000Z

Market Cap

21568632

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

-0.671

Sentiment Sources

1

Rating

4

Target Price

21

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

7610000

Operating Income

-7610000

Interest Expense

-

Pretax Income

-7549000

Net Income

-7549000

Eps

-1.8643897846554471

Dividends Per Share

1479000

Shares Outstanding

16850494

Income Tax Expense

-

EBITDA

-7500000

Operating Margin

-

Total Other Income Expense Net

61000

Cash

21061000

Short Term Investments

-

Receivables

-

Inventories

-

Total Current Assets

22649000

Property Plant Equipment

4347000

Total Assets

26996000

Payables

2219000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

9604000

Equity

17392000

Depreciation

49000

Change In Working Capital

735000

Cash From Operations

-6688000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

18339000

Net Change In Cash

11651000

PE

0.0007

PB

0.26307624080036796

ROE

-43.40501379944802

ROA

-27.96340198547933

FCF

-6688000

Fcf Percent

-

Piotroski FScore

1

Health Score

38

Deep Value Investing Score

8.5

Defensive Investing Score

6.5

Dividend Investing Score

1.5

Economic Moat Investing Score

3.3

Garp Investing Score

1.5

Growth Investing Score

0.5

Momentum Investing Score

2.5

Net Net Investing Score

3.5

Quality Investing Score

2

Value Investing Score

8.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

7610000

Quarters > 0 > income Statement > operating Income

-7610000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-7549000

Quarters > 0 > income Statement > net Income

-7549000

Quarters > 0 > income Statement > eps

-1.8643897846554471

Quarters > 0 > income Statement > dividends Per Share

1479000

Quarters > 0 > income Statement > shares Outstanding

4049046

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-7500000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

61000

Quarters > 0 > balance Sheet > cash

21061000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

22649000

Quarters > 0 > balance Sheet > property Plant Equipment

4347000

Quarters > 0 > balance Sheet > total Assets

26996000

Quarters > 0 > balance Sheet > payables

2219000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

9604000

Quarters > 0 > balance Sheet > equity

17392000

Quarters > 0 > cash Flow > net Income

-7549000

Quarters > 0 > cash Flow > depreciation

49000

Quarters > 0 > cash Flow > change In Working Capital

735000

Quarters > 0 > cash Flow > cash From Operations

-6688000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

18339000

Quarters > 0 > cash Flow > net Change In Cash

11651000

Quarters > 0 > ratios > PE

-1.8643897846554471

Quarters > 0 > ratios > PB

0.26307624080036796

Quarters > 0 > ratios > ROE

-43.40501379944802

Quarters > 0 > ratios > ROA

-27.96340198547933

Quarters > 0 > ratios > FCF

-6688000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

38

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

49000

Quarters > 1 > income Statement > gross Profit

-49000

Quarters > 1 > income Statement > operating Expenses

6226000

Quarters > 1 > income Statement > operating Income

-6226000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-6204000

Quarters > 1 > income Statement > net Income

-6204000

Quarters > 1 > income Statement > eps

-8.404807159530122

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

738149

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-6177000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

22000

Quarters > 1 > balance Sheet > cash

9410000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

11081000

Quarters > 1 > balance Sheet > property Plant Equipment

4543000

Quarters > 1 > balance Sheet > total Assets

15624000

Quarters > 1 > balance Sheet > payables

2903000

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

9100000

Quarters > 1 > balance Sheet > equity

6524000

Quarters > 1 > cash Flow > net Income

-6204000

Quarters > 1 > cash Flow > depreciation

49000

Quarters > 1 > cash Flow > change In Working Capital

-775000

Quarters > 1 > cash Flow > cash From Operations

-7093000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

14364000

Quarters > 1 > cash Flow > net Change In Cash

7271000

Quarters > 1 > ratios > PE

-8.404807159530122

Quarters > 1 > ratios > PB

0.1278522946045371

Quarters > 1 > ratios > ROE

-95.09503372164316

Quarters > 1 > ratios > ROA

-39.70814132104455

Quarters > 1 > ratios > FCF

-7093000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

31

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

61000

Quarters > 2 > income Statement > gross Profit

-61000

Quarters > 2 > income Statement > operating Expenses

6480000

Quarters > 2 > income Statement > operating Income

-6480000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-6408000

Quarters > 2 > income Statement > net Income

-6408000

Quarters > 2 > income Statement > eps

-87.87471544938427

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

72922

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-6419000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

72000

Quarters > 2 > balance Sheet > cash

2139000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

3607000

Quarters > 2 > balance Sheet > property Plant Equipment

4735000

Quarters > 2 > balance Sheet > total Assets

8342000

Quarters > 2 > balance Sheet > payables

3789000

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

9815000

Quarters > 2 > balance Sheet > equity

-1473000

Quarters > 2 > cash Flow > net Income

-6408000

Quarters > 2 > cash Flow > depreciation

61000

Quarters > 2 > cash Flow > change In Working Capital

406000

Quarters > 2 > cash Flow > cash From Operations

-6575000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

-6575000

Quarters > 2 > ratios > PE

-87.87471544938427

Quarters > 2 > ratios > PB

-0.05594152070604209

Quarters > 2 > ratios > ROE

435.030549898167

Quarters > 2 > ratios > ROA

-76.81611124430592

Quarters > 2 > ratios > FCF

-6575000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

38

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

71000

Quarters > 3 > income Statement > gross Profit

-71000

Quarters > 3 > income Statement > operating Expenses

6311000

Quarters > 3 > income Statement > operating Income

-6382000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

-6312000

Quarters > 3 > income Statement > net Income

-6312000

Quarters > 3 > income Statement > eps

-86.55824031156578

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

72922

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-6311000

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

70000

Quarters > 3 > balance Sheet > cash

8714000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

10659000

Quarters > 3 > balance Sheet > property Plant Equipment

4932000

Quarters > 3 > balance Sheet > total Assets

15591000

Quarters > 3 > balance Sheet > payables

3053000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

10836000

Quarters > 3 > balance Sheet > equity

4755000

Quarters > 3 > cash Flow > net Income

-6312000

Quarters > 3 > cash Flow > depreciation

71000

Quarters > 3 > cash Flow > change In Working Capital

554000

Quarters > 3 > cash Flow > cash From Operations

-5759000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

6720000

Quarters > 3 > cash Flow > net Change In Cash

961000

Quarters > 3 > ratios > PE

-86.55824031156578

Quarters > 3 > ratios > PB

0.01732951840168244

Quarters > 3 > ratios > ROE

-132.74447949526814

Quarters > 3 > ratios > ROA

-40.484895131806816

Quarters > 3 > ratios > FCF

-5759000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

28

Valuation > metrics > PE

0.0007

Valuation > metrics > PB

0.26307624080036796

Valuation > final Score

90

Valuation > verdict

86.8% Undervalued

Profitability > metrics > ROE

-43.40501379944802

Profitability > metrics > ROA

-33.33038986268709

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.5522079116835327

Risk > metrics > Interest Coverage

-155.30612244897958

Risk > final Score

-573

Risk > verdict

High

Liquidity > metrics > Current Ratio

10.206849932401983

Liquidity > metrics > Quick Ratio

10.206849932401983

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

50

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

55

Prev Profitabilities > 2

15

Prev Risks > 0

-892

Prev Risks > 1

-2326

Prev Risks > 2

-25510

Prev Liquidities > 0

100

Prev Liquidities > 1

58

Prev Liquidities > 2

100

Updated At

2025-12-14T00:14:05.548Z